Markets / IPO / Invicta Diagnostic

Invicta Diagnostic IPO

Updated 07:20

SME IPO on NSE Emerge · Healthcare Service Provider

● Listed 8 Dec 2025

SME · NSE Emerge · Healthcare Service Provider · issue ₹28.12 crore

Price now₹69.20-18.59% since IPO
Issue price₹85band ₹80–85
Listing (open)₹100.00+17.65%
First-day close₹96.70+13.76%
Subscribed–
Lot1600 shares₹2,72,000

How it has done since the IPO

Closing prices since listing: 26 Oct ₹63.00, 27 Oct ₹66.50, 28 Oct ₹65.00, 29 Oct ₹64.50, 30 Oct ₹64.50, 2 Nov ₹66.00, 3 Nov ₹67.00, 4 Nov ₹68.00, 5 Nov ₹68.30, 6 Nov ₹69.00.

Listing day8 Dec 2025
Open / high / low / close₹100.00 / ₹105.00 / ₹95.00 / ₹96.70
Shares traded on NSE13,63,200
Market value at the listing-day close₹122 cr

Invicta Diagnostic share price, live chart and technicals →

The IPO's journey

Anchor28 Nov
Opens1 Dec
Closes3 Dec
Allotment4 Dec
In demat5 Dec
Listing8 Dec
Lock-in 50%2 Jan
Lock-in rest3 Mar

Subscription

Shares offered and bid, by group
Investor categoryShares bid for
Institutions (QIB)18,75,200
HNI / NII39,40,800
  HNI, above ₹10 lakh28,06,400
  HNI, ₹2–10 lakh11,34,400
Total58,16,000

NSE does not publish the shares offered to each category for this issue, so times subscribed cannot be shown. NSE and BSE bids together, as of 3 Dec 2025 19:00.

Who the issue was for

Bids by price

Top price ₹85 99.65%Lower prices 0.3%

Applications from individual investors

1,363 applications in the individual investors' category (bidding for the minimum 2 lots).

NSE does not publish the shares set aside for this category for SME issues, so the chance of allotment cannot be worked out exactly. Winners are picked by lottery.

Lot size by investor type

ApplicationLotsSharesAmount
Individual investor (minimum)23,200₹2,72,000
HNI (minimum)34,800₹4,08,000

At ₹85 a share. In SME IPOs individuals must bid for at least 2 lots.

Anchor investors

Anchor bid date28 Nov 2025
Anchor shares7,98,400
Raised from anchors₹6.79 cr
Lock-in ends for the first 50% (30 days)2 Jan 2026
Lock-in ends for the remaining 50% (90 days)3 Mar 2026

Anchor investors are large funds that buy the day before the IPO opens. SEBI locks in half their shares for 30 days from the allotment and the rest for 90 days; they can sell from the next trading day. Traders watch these dates because extra selling can come in.

Financials and valuation

At issue priceNow
Market value₹107 cr₹87 cr
P/E (last 12 months' profit)––
Revenue, last 12 months–
Profit, last 12 months–
Return on equity–
Debt to equity0.07

From results the company filed with NSE (latest period to 31 Mar 2026). Twelve-month figures need four quarters of results, so they fill in over the first year after listing.

Other recent IPOs: Healthcare Service Provider

CompanyListedSubscribedOn listingSince IPO
Credent Connect N Care SME20 Aug–+90.00%+106.24%
Pramodini Medicare SME19 Aug–+1.69%-8.94%
Gaudium IVF and Women Health 27 Feb7.27×+5.06%+31.87%
Nephrocare Health Services 17 Dec13.96×+6.52%+30.82%
Chandan Healthcare SME17 Feb–+3.84%+47.48%
Suraksha Diagnostic 6 Dec1.27×-0.68%-24.37%

← All IPOs: open, upcoming and recently listed

From NSE's official IPO data. Expected dates follow SEBI's T+3 timetable; the exchange confirms them. Information only, not investment advice.

What is the Invicta Diagnostic IPO price band and lot size?

The price band is ₹80–85 per share, and one lot is 1600 shares (₹1,36,000 at the upper price).

When is the Invicta Diagnostic IPO allotment date?

Allotment was finalised on 4 Dec 2025, the next working day after bidding closed on 3 Dec 2025.

How many times was the Invicta Diagnostic IPO subscribed?

Subscription figures are not available yet.

What is the Invicta Diagnostic IPO listing date?

It listed on 8 Dec 2025 on NSE Emerge (SME).

When does the Invicta Diagnostic anchor lock-in end?

The 30-day lock-in on half of the anchor investors' shares ends on 2 Jan 2026 and the 90-day lock-in on the rest ends on 3 Mar 2026; they can sell from the next trading day.

What was the Invicta Diagnostic listing gain?

It opened at ₹100.00 against an issue price of ₹85, a gain of 17.65%. It is now down 18.59% from the issue price.